SMNR
Semnur Pharmaceuticals, Inc.
Key Financials
Net Income
$-160416000
↓ 95781.8%
Revenue
$50.0M
0.0%
Operating Income
$-160416000
↓ 9627.5%
EPS (Diluted)
$-0.78
↓ 3800.0%
Shareholders' Equity
$-20750000.00
↓ 99.2%
Total Assets
$1.3M
↓ 85.1%
Operating Cash Flow
$-5867000.00
↓ 678.8%
Cash & Equivalents
$20000.00
↑ 66.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| EFFECT | 5/18/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
| POS AM | 5/12/2026 | View on SEC |
| ARS | 4/30/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
| 8-K | 4/23/2026 | View on SEC |
| 8-K | 3/17/2026 | View on SEC |
| 10-K | 2/27/2026 | View on SEC |
| EFFECT | 12/29/2025 | View on SEC |
| 424B3 | 12/29/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SMNR |
| Company Name | Semnur Pharmaceuticals, Inc. |
| CIK | 1913577 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (650) 516-4310 |